{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T03:49:05Z","timestamp":1791776945975,"version":"4.3.4"},"reference-count":92,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006259","name":"Teva Pharmaceutical Industries","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006259","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.jaip.2022.09.010","type":"journal-article","created":{"date-parts":[[2022,9,21]],"date-time":"2022-09-21T11:17:55Z","timestamp":1663759075000},"page":"35-42","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":73,"title":["Nonallergic Rhinitis, Allergic Rhinitis, and Immunotherapy: Advances in the Last Decade"],"prefix":"10.1016","volume":"11","author":[{"given":"Punita","family":"Ponda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tara","family":"Carr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew A.","family":"Rank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Bousquet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2022.09.010_bib1","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1111\/all.13200","article-title":"Non-allergic rhinitis: position paper of the European Academy of Allergy and Clinical Immunology","volume":"72","author":"Hellings","year":"2017","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2022.09.010_bib2","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.jaci.2020.07.007","article-title":"Rhinitis 2020: a practice parameter update","volume":"146","author":"Dykewicz","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.09.010_bib3","doi-asserted-by":"crossref","DOI":"10.1002\/clt2.12130","article-title":"Worldwide prevalence of rhinitis in adults: a review of definitions and temporal evolution","volume":"12","author":"Savoure","year":"2022","journal-title":"Clin Transl Allergy"},{"key":"10.1016\/j.jaip.2022.09.010_bib4","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.jaci.2011.09.036","article-title":"Natural course and comorbidities of allergic and nonallergic rhinitis in children","volume":"129","author":"Westman","year":"2012","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.09.010_bib5","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1002\/ppul.22554","article-title":"Allergic rhinitis and non-allergic rhinitis in children in the tropics: prevalence and risk associations","volume":"47","author":"Chiang","year":"2012","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.jaip.2022.09.010_bib6","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S0140-6736(08)61446-4","article-title":"Rhinitis and onset of asthma: a longitudinal population-based study","volume":"372","author":"Shaaban","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2022.09.010_bib7","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/cea.13276","article-title":"Non-atopic rhinitis at age 6 is associated with subsequent development of asthma","volume":"49","author":"Carr","year":"2019","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2022.09.010_bib8","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.jaci.2018.07.041","article-title":"Rhinitis in children and adolescents with asthma: ubiquitous, difficult to control, and associated with asthma outcomes","volume":"143","author":"Togias","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.09.010_bib9","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s11882-022-01027-0","article-title":"Clinical evidence of type 2 inflammation in non-allergic rhinitis with eosinophilia syndrome: a systematic review","volume":"22","author":"De Corso","year":"2022","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.jaip.2022.09.010_bib10","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1111\/cea.13039","article-title":"Inflammatory proteins in nasal lavage of workers exposed to occupational agents","volume":"47","author":"Castano","year":"2017","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2022.09.010_bib11","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.anai.2016.07.006","article-title":"Empty nose syndrome and atrophic rhinitis","volume":"117","author":"Shah","year":"2016","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2022.09.010_bib12","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1159\/000513099","article-title":"Platelet-rich plasma injection in patients with atrophic rhinitis","volume":"83","author":"Kim","year":"2021","journal-title":"ORL J Otorhinolaryngol Relat Spec"},{"key":"10.1016\/j.jaip.2022.09.010_bib13","doi-asserted-by":"crossref","DOI":"10.1177\/0145561319870483","article-title":"Role of alpha-tocopherol acetate on nasal respiratory functions: mucociliary clearance and rhinomanometric evaluations in primary atrophic rhinitis","volume":"100","author":"Testa","year":"2021","journal-title":"Ear Nose Throat J"},{"key":"10.1016\/j.jaip.2022.09.010_bib14","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1111\/all.12255","article-title":"Nasal hyper-reactivity is a common feature in both allergic and nonallergic rhinitis","volume":"68","author":"Segboer","year":"2013","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2022.09.010_bib15","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1111\/all.15223","article-title":"The prevalence of non-allergic rhinitis phenotypes in the general population: a cross-sectional study","volume":"77","author":"Avdeeva","year":"2022","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2022.09.010_bib16","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1002\/lary.23495","article-title":"Short-time cold dry air exposure: a useful diagnostic tool for nasal hyperresponsiveness","volume":"122","author":"Van Gerven","year":"2012","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jaip.2022.09.010_bib17","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s11882-016-0638-1","article-title":"Capsaicin for rhinitis","volume":"16","author":"Fokkens","year":"2016","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.jaip.2022.09.010_bib18","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/j.jaci.2013.08.026","article-title":"Capsaicin treatment reduces nasal hyperreactivity and transient receptor potential cation channel subfamily V, receptor 1 (TRPV1) overexpression in patients with idiopathic rhinitis","volume":"133","author":"Van Gerven","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.09.010_bib19","doi-asserted-by":"crossref","first-page":"215","DOI":"10.2500\/ajra.2014.28.4059","article-title":"Azelastine desensitization of transient receptor potential vanilloid 1: a potential mechanism explaining its therapeutic effect in nonallergic rhinitis","volume":"28","author":"Singh","year":"2014","journal-title":"Am J Rhinol Allergy"},{"key":"10.1016\/j.jaip.2022.09.010_bib20","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.jaip.2016.10.010","article-title":"Findings from an online survey assessing the burden and management of seasonal allergic rhinoconjunctivitis in US patients","volume":"5","author":"Meltzer","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2022.09.010_bib21","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1038\/s41588-018-0157-1","article-title":"Genome-wide association and HLA fine-mapping studies identify risk loci and genetic pathways underlying allergic rhinitis","volume":"50","author":"Waage","year":"2018","journal-title":"Nat Genet"},{"key":"10.1016\/j.jaip.2022.09.010_bib22","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.jaci.2020.06.026","article-title":"Unsupervised modeling and genome-wide association identify novel features of allergic march trajectories","volume":"147","author":"Gabryszewski","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.09.010_bib23","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1111\/all.14177","article-title":"The need for clean air: the way air pollution and climate change affect allergic rhinitis and asthma","volume":"75","author":"Eguiluz-Gracia","year":"2020","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2022.09.010_bib24","article-title":"Nasal bacterial microbiome differs between healthy controls and those with asthma and allergic rhinitis","volume":"12","author":"Chen","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.jaip.2022.09.010_bib25","doi-asserted-by":"crossref","first-page":"3590","DOI":"10.1016\/j.jaip.2020.08.035","article-title":"Reduction of allergic rhinitis symptoms with face mask usage during the COVID-19 pandemic","volume":"8","author":"Dror","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2022.09.010_bib26","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.jaci.2017.08.039","article-title":"Histamine and T helper cytokine-driven epithelial barrier dysfunction in allergic rhinitis","volume":"141","author":"Steelant","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.09.010_bib27","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1016\/j.jaci.2019.04.027","article-title":"Blocking histone deacetylase activity as a novel target for epithelial barriers defects in patients with allergic rhinitis","volume":"144","author":"Steelant","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.09.010_bib28","doi-asserted-by":"crossref","first-page":"3248","DOI":"10.1111\/all.14314","article-title":"A\u00a0novel whole blood gene expression signature for asthma, dermatitis, and rhinitis multimorbidity in children and adolescents","volume":"75","author":"Lemonnier","year":"2020","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2022.09.010_bib29","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.jaci.2016.12.940","article-title":"Mechanisms of the Development of Allergy (MeDALL): introducing novel concepts in allergy phenotypes","volume":"139","author":"Anto","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.09.010_bib30","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1111\/cea.12897","article-title":"The sensitization pattern differs according to rhinitis and asthma multimorbidity in adults: the EGEA study","volume":"47","author":"Burte","year":"2017","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2022.09.010_bib31","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/cea.13192","article-title":"Local allergic rhinitis: implications for management","volume":"49","author":"Campo","year":"2019","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2022.09.010_bib32","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1016\/j.jaip.2019.12.012","article-title":"Children monosensitized to Can f 5 show different reactions to male and female dog allergen extract provocation: a randomized controlled trial","volume":"8","author":"Malby Schoos","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2022.09.010_bib33","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1016\/j.jaip.2019.01.015","article-title":"Validation of patient-reported outcomes for clinical trials in allergic rhinitis: a systematic review","volume":"7","author":"Calderon","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2022.09.010_bib34","first-page":"3320","article-title":"Omalizumab for the treatment of inadequately controlled allergic rhinitis: a systematic review and meta-analysis of randomized clinical trials","volume":"2","author":"Tsabouri","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2022.09.010_bib35","doi-asserted-by":"crossref","first-page":"3130","DOI":"10.1016\/j.jaip.2020.04.068","article-title":"Add-on omalizumab for inadequately controlled severe pollinosis despite standard-of-care: a randomized study","volume":"8","author":"Okubo","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2022.09.010_bib36","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.jaci.2017.11.051","article-title":"Efficacy and safety of dupilumab in perennial allergic rhinitis and comorbid asthma","volume":"142","author":"Weinstein","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.09.010_bib37","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1111\/all.13598","article-title":"Real-world benefits of allergen immunotherapy for birch pollen-associated allergic rhinitis and asthma","volume":"74","author":"Wahn","year":"2019","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2022.09.010_bib38","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/all.13213","article-title":"Sublingual immunotherapy provides long-term relief in allergic rhinitis and reduces the risk of asthma: a retrospective, real-world database analysis","volume":"73","author":"Zielen","year":"2018","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2022.09.010_bib39","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1016\/j.jaci.2016.09.043","article-title":"Efficacy and safety of the SQ house dust mite sublingual immunotherapy tablet in Japanese adults and adolescents with house dust mite-induced allergic rhinitis","volume":"139","author":"Okubo","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.09.010_bib40","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/j.jaci.2020.07.036","article-title":"A\u00a0300 IR sublingual tablet is an effective, safe treatment for house dust mite-induced allergic rhinitis: an international, double-blind, placebo-controlled, randomized phase III clinical trial","volume":"147","author":"Demoly","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.09.010_bib41","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1111\/all.13208","article-title":"Allergen immunotherapy for allergic asthma: a systematic review and meta-analysis","volume":"72","author":"Dhami","year":"2017","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2022.09.010_bib42","doi-asserted-by":"crossref","DOI":"10.1002\/clt2.12014","article-title":"ARIA-EAACI care pathways for allergen immunotherapy in respiratory allergy","volume":"11","author":"Bousquet","year":"2021","journal-title":"Clin Transl Allergy"},{"key":"10.1016\/j.jaip.2022.09.010_bib43","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.1016\/j.jaip.2020.04.071","article-title":"Clinical practice of allergen immunotherapy for allergic rhinoconjunctivitis and asthma: an expert panel report","volume":"8","author":"Calderon","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2022.09.010_bib44","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13601-015-0057-8","article-title":"Prolonged efficacy of the 300IR 5-grass pollen tablet up to 2 years after treatment cessation, as measured by a recommended daily combined score","volume":"5","author":"Didier","year":"2015","journal-title":"Clin Transl Allergy"},{"key":"10.1016\/j.jaip.2022.09.010_bib45","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1097\/ACI.0000000000000585","article-title":"Duration of allergen immunotherapy for inhalant allergy","volume":"19","author":"Penagos","year":"2019","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.09.010_bib46","doi-asserted-by":"crossref","first-page":"18","DOI":"10.4168\/aair.2018.10.1.18","article-title":"A\u00a0retrospective study of clinical response predictors in subcutaneous allergen immunotherapy with house dust mites for allergic rhinitis","volume":"10","author":"Lee","year":"2018","journal-title":"Allergy Asthma Immunol Res"},{"key":"10.1016\/j.jaip.2022.09.010_bib47","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/all.13254","article-title":"Health economic analysis of allergen immunotherapy for the management of allergic rhinitis, asthma, food allergy and venom allergy: a systematic overview","volume":"73","author":"Asaria","year":"2018","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2022.09.010_bib48","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/j.1365-2222.1986.tb01983.x","article-title":"Low dose sublingual therapy in patients with allergic rhinitis due to house dust mite","volume":"16","author":"Scadding","year":"1986","journal-title":"Clin Allergy"},{"key":"10.1016\/j.jaip.2022.09.010_bib49","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1016\/j.jaci.2012.02.026","article-title":"Intralymphatic immunotherapy for cat allergy induces tolerance after only 3 injections","volume":"129","author":"Senti","year":"2012","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.09.010_bib50","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1111\/cea.14138","article-title":"Intralymphatic immunotherapy with one or two allergens renders similar clinical response in patients with allergic rhinitis due to birch and grass pollen","volume":"52","author":"Ahlbeck","year":"2022","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2022.09.010_bib51","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1186\/s12931-021-01766-0","article-title":"Intralymphatic immunotherapy with tyrosine-adsorbed allergens: a double-blind, placebo-controlled trial","volume":"22","author":"Park","year":"2021","journal-title":"Respir Res"},{"key":"10.1016\/j.jaip.2022.09.010_bib52","doi-asserted-by":"crossref","first-page":"403","DOI":"10.2332\/allergolint.13-RAI-0650","article-title":"Allergen immunotherapy and tolerance","volume":"62","author":"Matsuoka","year":"2013","journal-title":"Allergol Int"},{"key":"10.1016\/j.jaip.2022.09.010_bib53","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1111\/all.13436","article-title":"Identification of specifically reduced Th2 cell subsets in allergic rhinitis patients after sublingual immunotherapy","volume":"73","author":"Ihara","year":"2018","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2022.09.010_bib54","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1126\/science.1257861","article-title":"Dynamic signaling by T follicular helper cells during germinal center B cell selection","volume":"345","author":"Shulman","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.jaip.2022.09.010_bib55","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1146\/annurev-immunol-041015-055605","article-title":"Follicular helper T cells","volume":"34","author":"Vinuesa","year":"2016","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.jaip.2022.09.010_bib56","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.alit.2020.08.002","article-title":"Mechanisms of allergen-specific immunotherapy and allergen tolerance","volume":"69","author":"Kucuksezer","year":"2020","journal-title":"Allergol Int"},{"key":"10.1016\/j.jaip.2022.09.010_bib57","doi-asserted-by":"crossref","first-page":"212","DOI":"10.3390\/cells11020212","article-title":"Allergen immunotherapy: current and future trends","volume":"11","author":"Pav\u00f3n-Romero","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.jaip.2022.09.010_bib58","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.jaci.2019.02.008","article-title":"Allergen immunotherapy improves defective follicular regulatory T cells in patients with allergic rhinitis","volume":"144","author":"Yao","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.09.010_bib59","article-title":"Can serum-specific IgE\/total IgE ratio predict clinical response to allergen-specific immunotherapy in children monosensitized to house dust mite?","volume":"2012","author":"Karakoc","year":"2012","journal-title":"J\u00a0Allergy (Cairo)"},{"key":"10.1016\/j.jaip.2022.09.010_bib60","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1159\/000365630","article-title":"Predictive factors for clinical response to allergy immunotherapy in children with asthma and rhinitis","volume":"164","author":"Li","year":"2014","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaip.2022.09.010_bib61","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1016\/j.jaip.2021.03.029","article-title":"Immunological responses and biomarkers for allergen-specific immunotherapy against inhaled allergens","volume":"9","author":"Shamji","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2022.09.010_bib62","doi-asserted-by":"crossref","DOI":"10.1002\/clt2.12128","article-title":"Allergen immunotherapy in MASK-air users in real-life: results of a Bayesian mixed-effects model","volume":"12","author":"Sousa-Pinto","year":"2022","journal-title":"Clin Transl Allergy"},{"key":"10.1016\/j.jaip.2022.09.010_bib63","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1016\/j.jaci.2020.12.640","article-title":"Component-resolved diagnostics in pet\u00a0allergy: current perspectives and future directions","volume":"147","author":"Schoos","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.09.010_bib64","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.aller.2018.03.002","article-title":"How molecular diagnosis may modify immunotherapy prescription in multi-sensitized pollen-allergic children","volume":"46","author":"Del-R\u00edo Camacho","year":"2018","journal-title":"Allergol Immunopathol (Madr)"},{"key":"10.1016\/j.jaip.2022.09.010_bib65","doi-asserted-by":"crossref","first-page":"3642","DOI":"10.1111\/all.14969","article-title":"Molecular allergology and its impact in specific allergy diagnosis and therapy","volume":"76","author":"Barber","year":"2021","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2022.09.010_bib66","doi-asserted-by":"crossref","first-page":"108","DOI":"10.2500\/aap.2020.41.200001","article-title":"Safety of allergen immunotherapy in North America from 2008-2017: lessons learned from the ACAAI\/AAAAI National Surveillance Study of adverse reactions to allergen immunotherapy","volume":"41","author":"Bernstein","year":"2020","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.jaip.2022.09.010_bib67","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/pai.13622","article-title":"Safety of allergen-specific immunotherapy in children","volume":"33","author":"De Filippo","year":"2022","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.jaip.2022.09.010_bib68","doi-asserted-by":"crossref","first-page":"177","DOI":"10.2217\/imt-2018-0143","article-title":"Fast up-dosing with a birch allergoid is safe and well tolerated in allergic rhinitis patients with or without asthma","volume":"11","author":"Zielen","year":"2019","journal-title":"Immunotherapy"},{"key":"10.1016\/j.jaip.2022.09.010_bib69","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1111\/all.12860","article-title":"A\u00a0randomized, 5-arm dose finding study with a mite allergoid SCIT in allergic rhinoconjunctivitis patients","volume":"71","author":"Pfaar","year":"2016","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2022.09.010_bib70","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1159\/000503684","article-title":"Accelerated dose escalation with three injections of an aluminum hydroxide-adsorbed allergoid preparation of six grasses is safe for patients with moderate to severe allergic rhinitis","volume":"181","author":"Kopp","year":"2020","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaip.2022.09.010_bib71","doi-asserted-by":"crossref","DOI":"10.1002\/clt2.12037","article-title":"A\u00a0meta-analysis on allergen-specific immunotherapy using MCT\u00ae (MicroCrystalline Tyrosine)-adsorbed allergoids in pollen allergic patients suffering from allergic rhinoconjunctivitis","volume":"11","author":"Becker","year":"2021","journal-title":"Clin Transl Allergy"},{"key":"10.1016\/j.jaip.2022.09.010_bib72","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1111\/cea.13840","article-title":"Peptide allergen-specific immunotherapy for allergic airway diseases\u2014state of the art","volume":"51","author":"Wraith","year":"2021","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2022.09.010_bib73","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.jaci.2017.03.050","article-title":"Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines\u20142016 revision","volume":"140","author":"Brozek","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.09.010_bib74","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.anai.2017.08.012","article-title":"Treatment of seasonal allergic rhinitis: an evidence-based focused 2017 guideline update","volume":"119","author":"Dykewicz","year":"2017","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2022.09.010_bib75","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1111\/cea.12953","article-title":"BSACI guideline for the diagnosis and management of allergic and non-allergic rhinitis (Revised Edition 2017; First edition 2007)","volume":"47","author":"Scadding","year":"2017","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2022.09.010_bib76","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jaci.2019.06.049","article-title":"Next-generation Allergic Rhinitis and Its Impact on Asthma (ARIA) guidelines for allergic rhinitis based on Grading of Recommendations Assessment, Development and Evaluation (GRADE) and real-world evidence","volume":"145","author":"Bousquet","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.09.010_bib77","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1111\/all.13420","article-title":"EAACI guidelines on allergen immunotherapy: executive statement","volume":"73","author":"Muraro","year":"2018","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2022.09.010_bib78","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1111\/all.13317","article-title":"EAACI Guidelines on Allergen Immunotherapy: allergic rhinoconjunctivitis","volume":"73","author":"Roberts","year":"2018","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2022.09.010_bib79","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1111\/all.13749","article-title":"EAACI Guidelines on Allergen Immunotherapy: house dust mite-driven allergic asthma","volume":"74","author":"Agache","year":"2019","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2022.09.010_bib80","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1111\/all.13805","article-title":"2019 ARIA Care pathways for allergen immunotherapy","volume":"74","author":"Bousquet","year":"2019","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2022.09.010_bib81","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1111\/all.13701","volume":"74","author":"Bosnic-Anticevich","year":"2019","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2022.09.010_bib82","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1016\/j.jaip.2019.07.044","article-title":"Mobile technology in allergic rhinitis: evolution in management or revolution in health and care?","volume":"7","author":"Bousquet","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2022.09.010_bib83","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1016\/j.jaip.2021.02.035","article-title":"The role of mobile health technologies in stratifying patients for AIT and its cessation. The ARIA-EAACI perspective","volume":"9","author":"Bousquet","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2022.09.010_bib84","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jaci.2019.01.053","article-title":"Mobile technology offers novel insights into the control and treatment of allergic rhinitis: the MASK study","volume":"144","author":"B\u00e9dard","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.09.010_bib85","doi-asserted-by":"crossref","DOI":"10.1002\/clt2.12062","article-title":"Validity, reliability, and responsiveness of daily monitoring visual analog scales in MASK-air(R)","volume":"11","author":"Sousa-Pinto","year":"2021","journal-title":"Clin Transl Allergy"},{"key":"10.1016\/j.jaip.2022.09.010_bib86","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/all.14422","article-title":"ARIA digital anamorphosis: digital transformation of health and care in airway diseases from research to practice","volume":"76","author":"Bousquet","year":"2021","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2022.09.010_bib87","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s13601-020-00321-2","volume":"10","author":"Bousquet","year":"2020","journal-title":"Clin Transl Allergy"},{"key":"10.1016\/j.jaip.2022.09.010_bib88","doi-asserted-by":"crossref","DOI":"10.2196\/16642","article-title":"Adherence to prescribed E-diary recording by patients with seasonal allergic rhinitis: observational study","volume":"22","author":"Di Fraia","year":"2020","journal-title":"J\u00a0Med Internet Res"},{"key":"10.1016\/j.jaip.2022.09.010_bib89","doi-asserted-by":"crossref","DOI":"10.1002\/clt2.12084","article-title":"Heterogeneous validity of daily data on symptoms of seasonal allergic rhinitis recorded by patients using the e-diary AllergyMonitor(R)","volume":"11","author":"Dramburg","year":"2021","journal-title":"Clin Transl Allergy"},{"key":"10.1016\/j.jaip.2022.09.010_bib90","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/s13052-020-00870-z","article-title":"Digital technologies for an improved management of respiratory allergic diseases: 10 years of clinical studies using an online platform for patients and physicians","volume":"46","author":"Tripodi","year":"2020","journal-title":"Ital J Pediatr"},{"key":"10.1016\/j.jaip.2022.09.010_bib91","doi-asserted-by":"crossref","DOI":"10.2196\/16767","article-title":"Translating the burden of pollen allergy into numbers using electronically generated symptom data from the patient\u2019s hayfever diary in Austria and Germany: 10-year observational study","volume":"22","author":"Bastl","year":"2020","journal-title":"J\u00a0Med Internet Res"},{"key":"10.1016\/j.jaip.2022.09.010_bib92","doi-asserted-by":"crossref","DOI":"10.1016\/j.waojou.2022.100661","article-title":"Digital tools in allergy and respiratory care","volume":"15","author":"Verhoeven","year":"2022","journal-title":"World Allergy Organ J"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221321982200945X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221321982200945X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:36:16Z","timestamp":1761975376000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221321982200945X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":92,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["S221321982200945X"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2022.09.010","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nonallergic Rhinitis, Allergic Rhinitis, and Immunotherapy: Advances in the Last Decade","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2022.09.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}